SIRIC ILIAD’s research on breast cancer in video
Video : Introduction to SIRIC ILIAD’s research work on breast cancer The SIRIC ILIAD Nantes-Angers (Integrated Cancer Research Site) was
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer : The OPALESCENCE study, a collaborative research
Nantes research on astatine in the spotlight
Nantes research on astatine in the spotlight Astatine (At) is the rarest chemical element on Earth, and its 211 isotope
The European Medical Radionuclides Programme – PRISMAP – Arronax
GIP ARRONAX is part of the European medical isotope programme PRISMAP, which aims to fundamentally change the European medical radionuclide
The Scientific Advisory Board (SAB) of SIRIC ILIAD met on 16 & 17 September 2021
The International Scientific Advisory Board (SAB) met on 16 & 17 September 2021: review and improvement perspectives The role of
4th SIRIC ILIAD Scientific Day – 11 October 2021 – Nantes
The SIRIC ILIAD is organising its 4th scientific day on Monday 11 October 2021 in Nantes. The aim of
SIRIC ILIAD shares the progress of its research with its partners | Review 2020-2021
The SIRIC ILIAD Partners’ Committee met on 31 August to present its 2020-2021 results. On August 31, 2021, the fourth
SIRIC ILIAD partners with the Multimodal Imaging Centre of the Grand-Ouest: IMRAM
As a result of a partnership between Nantes University Hospital and the Western Cancer Institute (ICO), the new shared medical
SAVE THE DATE | Meeting on minds on Breast Cancer: From Research to Patients – 6 Oct 2021
The SIRIC ILIAD and the Cancéropôle Grand Ouest (CGO) are organising a public event on breast cancer as part
Seminar “Return to work after cancer” | 19 November 2021
The ReWork-QoL programme of the SIRIC ILIAD and the Human and Social Sciences network of the Cancéropôle Grand-Ouest are organising
